Mitofusin 2 displays fusion-independent roles in proteostasis surveillance

Mariana Joaquim1,2,3, Selver Altin1,2, Maria-Bianca Bulimaga1,2,3,4

  • 1Institute for Genetics, University of Cologne, Cologne, Germany.

Nature Communications
|February 10, 2025
PubMed

Insights

Mitofusin 2 (MFN2) acts as a crucial gatekeeper for cellular proteostasis, preventing protein aggregation independently of its role in mitochondrial shape. This discovery offers new therapeutic avenues targeting MFN2.

Area of Science:

  • Cell Biology
  • Mitochondrial Biology
  • Proteostasis

Background:

  • Mitochondria are vital organelles regulating cellular protein homeostasis (proteostasis).
  • The molecular mechanisms governing mitochondrial quality control, particularly under basal conditions, remain incompletely understood.
  • Mitofusins (MFNs) are key proteins involved in mitochondrial dynamics.

Purpose of the Study:

  • To investigate the role of Mitofusin 2 (MFN2) in cellular proteostasis beyond its known function in mitochondrial fusion.
  • To identify molecular interactions and pathways regulated by MFN2 in maintaining protein quality control.
  • To explore the implications of MFN2 dysfunction in disease contexts.

Main Methods:

  • Mitochondrial protein analysis in MFN2 knockout (KO) cells and patient fibroblasts.
  • Co-immunoprecipitation assays to identify MFN2 interacting partners.
  • Assessment of protein aggregation and cellular proteostasis markers.
  • Functional rescue experiments by restoring MFN2 levels.

Main Results:

  • MFN2 deficiency leads to altered cellular proteome, including reduced import machinery and PINK1 accumulation.
  • MFN2 interacts with the proteasome and cytosolic chaperones, preventing protein aggregation.
  • Patient fibroblasts with MFN2 mutations exhibit significant protein aggregation defects.
  • MFN2 re-expression rescues proteostasis and mitochondrial fusion defects.

Conclusions:

  • MFN2 plays a critical, fusion-independent role in maintaining cellular proteostasis by preventing protein aggregation.
  • MFN2 acts as a molecular gatekeeper for quality control, interacting with the proteasome and chaperones.
  • Dysfunction of MFN2 underlies protein aggregation pathologies observed in MFN2-related diseases.
  • Modulating MFN2 levels presents a potential therapeutic strategy for enhancing cellular homeostasis.

Related Concept Videos

Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
3.0K
Mitochondrial Protein Sorting01:39

Mitochondrial Protein Sorting

Mitochondria are double-membrane organelles of the eukaryotes involved in cellular metabolism, signaling, ATP synthesis, and programmed cell death.  Each of these processes requires specific proteins and enzymes that must be correctly sorted to the right mitochondrial subcompartment for the proper functioning of the organelle.
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...
4.2K
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
2.4K
Mitochondrial Precursor Proteins01:39

Mitochondrial Precursor Proteins

Mitochondrial precursors are partially unfolded or loosely folded polypeptide chains. Newly synthesized precursors are inhibited from spontaneously folding into their native conformation by the cytosolic chaperones, heat shock proteins 70 (Hsp70), and mitochondrial import stimulation factors (MSFs). Precursors bound to MSFs are guided to the TOM70-TOM37 receptors, while precursors bound to Hsp70  chaperones are targetted to TOM20-TOM22 receptor complexes.
Most of the mitochondrial...
2.5K
Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
2.6K
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.5K